BSI Merges with MBC to Secure Access to Nanoarray Technology and New Academic and Pharma Markets
September 17, 2010
BSI Merges with MBC to Secure Access to Nanoarray Technology and New Academic and Pharma Markets
The merger will give Biosystems International access to MicroBioChips' nanoarray technology and its sales and marketing resources, which are expected to help the company establish new relationships with university-based proteomics laboratories and pharma and biotech firms.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BSI Closes €2.1M Funding Round for Development of Protein Biomarker Lung Cancer Test
July 23, 2010 / ProteoMonitor - Researchers ID Gastric Cancer Biomarker Aimed for Use in DTC Tests in US, China
May 6, 2011 / ProteoMonitor - BSI Partnering with Pharnext on $14.2M Initiative to Develop Biomarkers and Therapeutics for AD
November 19, 2010 / ProteoMonitor - TGen's Center for Proteomics Named a Waters Center of Innovation
August 26, 2011 / ProteoMonitor - Taking Aim at Clinical Oncology Market, Proteome Sciences Developing SRM-MS Assay for ER Status
July 22, 2011 / ProteoMonitor